Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Nakano

Showing results (71-80 of 94) with videos related to

Pageof 10
Sort By:
Transplantation Proceedings|February 7, 2024
Donor Age Correlates With Liver-Resident Natural Killer Cell Activity in Adoptive Immunotherapy Using Donor Liver Natural Killer Cells in Liver TransplantationMasahiro Ohira, Kouki Imaoka, Tomoaki Bekki, et al.
Cytotechnology|November 13, 2008
Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodiesKatsuhiro Mori, Shigeru Iida, Naoko Yamane-Ohnuki, et al.
Biotechnology and Bioengineering|April 13, 2006
Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCCYutaka Kanda, Naoko Yamane-Ohnuki, Naoto Sakai, et al.
Transplantation|December 10, 2024
Exercise Preconditioning of the Donor Liver Decreases Cold Ischemia/Reperfusion Injury in a Mouse ModelHamza O Yazdani, Ruiqi Yang, Tony Haykal, et al.
Transplantation Proceedings|February 8, 2024
Anti-Donor T-Cell Responses Are Not Necessarily Attenuated During Cytomegalovirus Infection in Kidney Transplant RecipientsKentaro Ide, Asuka Tanaka, Yuka Tanaka, et al.
Inflammatory Bowel Diseases|May 11, 2024
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative ColitisDai Ishikawa, Xiaochen Zhang, Kei Nomura, et al.
Plos One|January 17, 2025
A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantationMasahiro Ohira, Yuki Imaoka, Koki Sato, et al.
International Journal of Surgery Protocols|March 4, 2024
Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II studyYosuke Namba, Tsuyoshi Kobayashi, Shintaro Kuroda, et al.
In Vivo (Athens, Greece)|October 30, 2024
Sarcopenia's Impact Defined by Grip Strength and Muscle Mass on Post-hepatectomy Outcomes: A Multicenter AnalysisSotaro Fukuhara, Tsuyoshi Kobayashi, Michinori Hamaoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 15, 2025
Usefulness of preoperative peripheral blood GPC3-positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort studyYosuke Namba, Tsuyoshi Kobayashi, Yoshito Hirata, et al.
Pageof 10

Showing results (71-80 of 94) with videos related to

Sort By:
Pageof 10
Transplantation Proceedings|February 7, 2024
Donor Age Correlates With Liver-Resident Natural Killer Cell Activity in Adoptive Immunotherapy Using Donor Liver Natural Killer Cells in Liver TransplantationMasahiro Ohira, Kouki Imaoka, Tomoaki Bekki, et al.
Cytotechnology|November 13, 2008
Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodiesKatsuhiro Mori, Shigeru Iida, Naoko Yamane-Ohnuki, et al.
Biotechnology and Bioengineering|April 13, 2006
Comparison of cell lines for stable production of fucose-negative antibodies with enhanced ADCCYutaka Kanda, Naoko Yamane-Ohnuki, Naoto Sakai, et al.
Transplantation|December 10, 2024
Exercise Preconditioning of the Donor Liver Decreases Cold Ischemia/Reperfusion Injury in a Mouse ModelHamza O Yazdani, Ruiqi Yang, Tony Haykal, et al.
Transplantation Proceedings|February 8, 2024
Anti-Donor T-Cell Responses Are Not Necessarily Attenuated During Cytomegalovirus Infection in Kidney Transplant RecipientsKentaro Ide, Asuka Tanaka, Yuka Tanaka, et al.
Inflammatory Bowel Diseases|May 11, 2024
Anti-inflammatory Effects of Bacteroidota Strains Derived From Outstanding Donors of Fecal Microbiota Transplantation for the Treatment of Ulcerative ColitisDai Ishikawa, Xiaochen Zhang, Kei Nomura, et al.
Plos One|January 17, 2025
A phase I/II study of adoptive immunotherapy using donor liver graft-derived NK cell-enriched immune cells to prevent severe infection after liver transplantationMasahiro Ohira, Yuki Imaoka, Koki Sato, et al.
International Journal of Surgery Protocols|March 4, 2024
Protocol to evaluate the efficacy and safety of tolvaptan in patients with refractory ascites after liver resection: an open-label, single-arm phase I/II studyYosuke Namba, Tsuyoshi Kobayashi, Shintaro Kuroda, et al.
In Vivo (Athens, Greece)|October 30, 2024
Sarcopenia's Impact Defined by Grip Strength and Muscle Mass on Post-hepatectomy Outcomes: A Multicenter AnalysisSotaro Fukuhara, Tsuyoshi Kobayashi, Michinori Hamaoka, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|May 15, 2025
Usefulness of preoperative peripheral blood GPC3-positive circulating tumor cells in subclassification of Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma: a retrospective cohort studyYosuke Namba, Tsuyoshi Kobayashi, Yoshito Hirata, et al.
Pageof 10